Walter Curran, MD, FACR, has been named professor and chair of the Department of Radiation Oncology at Emory University School of Medicine and chief medical officer of the Winship Cancer Institute. The announcement was made today by Thomas J. Lawley, MD, dean of the School of Medicine, and Brian Leyland-Jones, MD, PhD, director of the Winship Cancer Institute.
Dr. Curran joins Emory from the Jefferson Medical College at Thomas Jefferson University in Philadelphia, where he served as professor and chair of the Department of Radiation Oncology and clinical director for the Kimmel Cancer Center.
“Dr. Curran is one of this nation’s most respected radiation oncologists,” says Thomas J. Lawley, MD, dean of the School of Medicine. “Dr. Curran’s work has advanced the body of knowledge in the treatment of aerodigestive and neurologic malignancies.”
Dr. Curran currently is the group chairman and principal investigator of the Radiation Therapy Oncology Group (RTOG), a National Cancer Institute-funded international, multi-institutional cooperative group dedicated to advancing patient treatment and care through cooperative clinical trials and research. He will continue to serve in this role after assuming his responsibilities at Emory.
“Winship’s unique capacity in translational cancer medicine and clinical trials provides a perfect complement to Dr. Curran’s chairmanship of RTOG,” says Dr. Leyland-Jones. Dr. Curran previously served as chairman of the RTOG Brain Tumor Committee.
Dr. Curran is a Fellow in the American College of Radiology and holds honorary memberships in the European Society of Therapeutic Radiology and Oncology and the Canadian Association of Radiation Oncology. In 2006, he was named the leading radiation oncologist/cancer researcher in a peer survey by the journal Medical Imaging.